CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $34,000 | -35.8% | 18,624 | -28.4% | 0.00% | – |
| Q1 2022 | $53,000 | -8.6% | 26,024 | +21.3% | 0.00% | – |
| Q4 2021 | $58,000 | -18.3% | 21,456 | +34.3% | 0.00% | – |
| Q3 2021 | $71,000 | +10.9% | 15,977 | +44.0% | 0.00% | – |
| Q2 2021 | $64,000 | -85.6% | 11,092 | +13.9% | 0.00% | -100.0% |
| Q2 2018 | $443,000 | -18.6% | 9,742 | -5.4% | 0.00% | -25.0% |
| Q1 2018 | $544,000 | -48.9% | 10,295 | -34.2% | 0.00% | -42.9% |
| Q4 2017 | $1,064,000 | +239.9% | 15,644 | +311.8% | 0.01% | +250.0% |
| Q3 2017 | $313,000 | +4.0% | 3,799 | +18.3% | 0.00% | 0.0% |
| Q2 2017 | $301,000 | +47.5% | 3,211 | +0.2% | 0.00% | +100.0% |
| Q1 2017 | $204,000 | +209.1% | 3,205 | -33.6% | 0.00% | – |
| Q2 2016 | $66,000 | -8.3% | 4,827 | +28.5% | 0.00% | – |
| Q1 2016 | $72,000 | -30.8% | 3,755 | +26.8% | 0.00% | -100.0% |
| Q4 2015 | $104,000 | -69.4% | 2,961 | -20.0% | 0.00% | -66.7% |
| Q3 2015 | $340,000 | -94.5% | 3,701 | -94.7% | 0.00% | -93.5% |
| Q2 2015 | $6,142,000 | +12184.0% | 69,895 | +10332.1% | 0.05% | – |
| Q1 2015 | $50,000 | +38.9% | 670 | +4.0% | 0.00% | – |
| Q4 2014 | $36,000 | 0.0% | 644 | -19.8% | 0.00% | – |
| Q3 2014 | $36,000 | +24.1% | 803 | +15.4% | 0.00% | – |
| Q2 2014 | $29,000 | -39.6% | 696 | 0.0% | 0.00% | – |
| Q1 2014 | $48,000 | +4.3% | 696 | -8.3% | 0.00% | – |
| Q4 2013 | $46,000 | -98.9% | 759 | -98.9% | 0.00% | -100.0% |
| Q3 2013 | $4,317,000 | -7.5% | 71,023 | +1.9% | 0.04% | -11.6% |
| Q2 2013 | $4,667,000 | – | 69,675 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |